Epm2aem1Pro
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Epm2aem1Pro |
| Name: |
epilepsy, progressive myoclonic epilepsy, type 2 gene alpha; endonuclease-mediated mutation 1, Peter J Roach |
| MGI ID: |
MGI:7643617 |
| Synonyms: |
LaforinC265S |
| Gene: |
Epm2a Location: Chr10:11219148-11335388 bp, + strand Genetic Position: Chr10, 3.66 cM, cytoband A
|
| Alliance: |
Epm2aem1Pro page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Not Applicable) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: Cysteine codon 265 (TGC) in exon 4 was changed to serine (TCT) (p.C265S) using an sgRNA (targeting GTGTATGTCCACTGCAACGC) and an ssODN template with CRISPR/Cas9 technology. The mutation renders the encoded peptide catalytically inactive.
(J:348085)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Epm2a Mutation: |
25 strains or lines available
|
|
| Original: |
J:348085 Skurat AV, et al., Impaired malin expression and interaction with partner proteins in Lafora disease. J Biol Chem. 2024 Apr 7;300(5):107271 |
| All: |
1 reference(s) |
|